FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186672731> ?p ?o ?g. }

• W3186672731 endingPage "e048198" @default.
• W3186672731 startingPage "e048198" @default.
• W3186672731 abstract "Introduction Myasthenia gravis (MG) is a rare, chronic, autoimmune disease, mediated by immunoglobulin G antibodies, which causes debilitating muscle weakness. As with most rare diseases, there is little patient-reported data with which to understand and address patient needs. This study explores the impact of MG in the real world from the patient perspective. Methods and analysis This is a 2-year prospective, observational, digital, longitudinal study of adults with MG, resident in the following countries: the USA, Japan, Germany, France, the UK, Italy, Spain, Canada and Belgium. The planned sample size is 2000. Recruitment will be community based, via patient advocacy groups, social media and word of mouth. Participants will use a smartphone application (app) to check eligibility, provide consent and contribute data. Planned data entry is as follows: (1) personal profile on enrollment—covering demographics, MG characteristics and previous care; (2) monthly event tracker—current treatments, healthcare visits, treatment-related adverse events, productivity losses; (3) monthly selection of validated generic and disease-specific patient-reported outcomes instruments: EQ-5D-5L, Myasthenia Gravis Activities of Daily Living, Myasthenia Gravis Quality of Life 15-item revised scale, Hospital Anxiety and Depression Scale and Health Utilities Index III. Analyses are planned for when the study has been running in most countries for approximately 6, 12, 18 and 24 months. Ethics and dissemination The study protocol has been reviewed and granted ethics approval by Salus IRB for participants resident in the following countries: Germany, the UK and the US. Local ethics approval is being sought for the following study countries: Belgium, Canada, France, Italy, Japan and Spain. Study results will be communicated to the public and participants via conference presentations and journal publications, as well as regular email, social media and in-application communication. Trial registration number NCT04176211 ." @default.
• W3186672731 created "2021-08-02" @default.
• W3186672731 creator A5010222471 @default.
• W3186672731 creator A5018399596 @default.
• W3186672731 creator A5020933378 @default.
• W3186672731 creator A5031570157 @default.
• W3186672731 creator A5032850040 @default.
• W3186672731 creator A5035171547 @default.
• W3186672731 creator A5036631954 @default.
• W3186672731 creator A5040643971 @default.
• W3186672731 creator A5043932217 @default.
• W3186672731 creator A5044582269 @default.
• W3186672731 creator A5057286754 @default.
• W3186672731 creator A5077281690 @default.
• W3186672731 creator A5078239122 @default.
• W3186672731 creator A5090639952 @default.
• W3186672731 date "2021-07-01" @default.
• W3186672731 modified "2023-10-17" @default.
• W3186672731 title "Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)" @default.
• W3186672731 cites W1902089178 @default.
• W3186672731 cites W1967368852 @default.
• W3186672731 cites W1983404333 @default.
• W3186672731 cites W1990166011 @default.
• W3186672731 cites W2035464802 @default.
• W3186672731 cites W2037092176 @default.
• W3186672731 cites W2042968563 @default.
• W3186672731 cites W2054818438 @default.
• W3186672731 cites W2063931484 @default.
• W3186672731 cites W2065357689 @default.
• W3186672731 cites W2065445303 @default.
• W3186672731 cites W2075263835 @default.
• W3186672731 cites W2101388726 @default.
• W3186672731 cites W2102703420 @default.
• W3186672731 cites W2116638944 @default.
• W3186672731 cites W2117751651 @default.
• W3186672731 cites W2123731102 @default.
• W3186672731 cites W2132605328 @default.
• W3186672731 cites W2137544340 @default.
• W3186672731 cites W2143712834 @default.
• W3186672731 cites W2158750300 @default.
• W3186672731 cites W2166281097 @default.
• W3186672731 cites W2461303519 @default.
• W3186672731 cites W2473388648 @default.
• W3186672731 cites W2831910494 @default.
• W3186672731 cites W2887050320 @default.
• W3186672731 cites W2944903400 @default.
• W3186672731 cites W2961792602 @default.
• W3186672731 cites W2995690790 @default.
• W3186672731 cites W4211188347 @default.
• W3186672731 doi "https://doi.org/10.1136/bmjopen-2020-048198" @default.
• W3186672731 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8292816" @default.
• W3186672731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34285010" @default.
• W3186672731 hasPublicationYear "2021" @default.
• W3186672731 type Work @default.
• W3186672731 sameAs 3186672731 @default.
• W3186672731 citedByCount "10" @default.
• W3186672731 countsByYear W31866727312022 @default.
• W3186672731 countsByYear W31866727312023 @default.
• W3186672731 crossrefType "journal-article" @default.
• W3186672731 hasAuthorship W3186672731A5010222471 @default.
• W3186672731 hasAuthorship W3186672731A5018399596 @default.
• W3186672731 hasAuthorship W3186672731A5020933378 @default.
• W3186672731 hasAuthorship W3186672731A5031570157 @default.
• W3186672731 hasAuthorship W3186672731A5032850040 @default.
• W3186672731 hasAuthorship W3186672731A5035171547 @default.
• W3186672731 hasAuthorship W3186672731A5036631954 @default.
• W3186672731 hasAuthorship W3186672731A5040643971 @default.
• W3186672731 hasAuthorship W3186672731A5043932217 @default.
• W3186672731 hasAuthorship W3186672731A5044582269 @default.
• W3186672731 hasAuthorship W3186672731A5057286754 @default.
• W3186672731 hasAuthorship W3186672731A5077281690 @default.
• W3186672731 hasAuthorship W3186672731A5078239122 @default.
• W3186672731 hasAuthorship W3186672731A5090639952 @default.
• W3186672731 hasBestOaLocation W31866727311 @default.
• W3186672731 hasConcept C118552586 @default.
• W3186672731 hasConcept C126322002 @default.
• W3186672731 hasConcept C142724271 @default.
• W3186672731 hasConcept C153997805 @default.
• W3186672731 hasConcept C159110408 @default.
• W3186672731 hasConcept C160735492 @default.
• W3186672731 hasConcept C162324750 @default.
• W3186672731 hasConcept C204787440 @default.
• W3186672731 hasConcept C23131810 @default.
• W3186672731 hasConcept C2778105408 @default.
• W3186672731 hasConcept C2779951463 @default.
• W3186672731 hasConcept C50522688 @default.
• W3186672731 hasConcept C512399662 @default.
• W3186672731 hasConcept C558461103 @default.
• W3186672731 hasConcept C68122502 @default.
• W3186672731 hasConcept C71924100 @default.
• W3186672731 hasConceptScore W3186672731C118552586 @default.
• W3186672731 hasConceptScore W3186672731C126322002 @default.
• W3186672731 hasConceptScore W3186672731C142724271 @default.
• W3186672731 hasConceptScore W3186672731C153997805 @default.
• W3186672731 hasConceptScore W3186672731C159110408 @default.
• W3186672731 hasConceptScore W3186672731C160735492 @default.
• W3186672731 hasConceptScore W3186672731C162324750 @default.
• W3186672731 hasConceptScore W3186672731C204787440 @default.

• next